Asia Pacific Newborn Screening; Help Detect Presence of Over 100+ Medical Conditions That Can Be Hidden At Birth
Newborn
Screening Market |
Asia Pacific newborn screening is used to screen infants soon after birth for conditions that are treatable but not clinically evident in the neonatal period. Newborn Screening is a program that identifies babies at risk of having rare, but serious medical conditions that can affect normal development. There are three parts to newborn screening, such as the blood test (or heel stick), the hearing screen, and pulse oximetry. During the blood test, the baby’s heel will be pricked to collect a small sample of blood.
The
blood drops are collected in a small vial or on a special paper. The blood is
then sent for testing. With a simple blood test, doctors can check for rare
genetic, hormone-related, and metabolic conditions that can cause serious
health problems. The newborn hearing test is called the automated otoacoustic
emission (AOAE) test. The test helps ensure all babies who are deaf or hard of
hearing are identified as soon as possible. The newborn hearing screening test
helps identify babies who have permanent hearing loss as early as possible.
Pulse
oximetry is a non-invasive test that measures how much oxygen is in the baby's
blood. Low levels of oxygen in the blood can be a sign of a critical CHD (CHDs
are present at birth and can affect the structure of a baby's heart and the way
it works). The test is done using a machine called a pulse oximeter, with
sensors placed on the baby's skin. Pulse oximetry was recommended as a
screening tool to detect critical CHD in 2011 by the American Academy of
Pediatrics and the American Heart Association.
In Short, Asia
Pacific Newborn Screening Market allows
health professionals to identify and treat certain conditions before they make
a baby sick. Most babies with these conditions who are identified at birth and
treated early are able to grow up healthy with normal development.
Comments
Post a Comment